Abstract:expected from implantable cardioverter-defibrillator therapy in coronary artery disease patients presenting exclusively with ven-tricular fibrillation? JAm Coil Cardiol. 1992;19-208A. Abstract. The report by Ito and colleagues' constitutes an advancement in our capabilities of assessing the progress of functional recovery of postischemic myocardium in patients with acute anterior infarc-tion, particularly because the monitoring of the degrees of residual mechanical impairment was done in the context of the extent of the initial ischemic area at risk. The authors should be commended for combining the information attained by myocardial contrast echocardiography2 and the data from quantitative echocardiographical assessment of regional contraction abnormal-ities3 in some patients who received thrombolysis and some others who were not given such therapy. Although the invasive component of their study (intracoronary injection of contrast solution) constitutes an impediment for routine implementation of this monitoring technique to patients with acute anterior myocardial infarction, further research in this field is needed to investigate the possibility that the segment length of abnormal contraction prior to thrombolysis can be regarded as an index of the ischemic area at risk and that the acquisition of myocardial contrast echocardiographical data may not offer additional information. If such proof becomes available, one can dispense with the intracoronary injection of contrast medium, rendering the method clinically applicable. I have only one criticism with this otherwise excellent study: Because, as the authors stated in "Results," "the value for AS/CD before coronary reflow was 1.00±0.02, suggesting that lengths of segments showing abnormal contraction coincide with those of the contrast defect segment," the essence of such important finding should have been included in the "message" of the article as part of the "clinical implications." Instead, the authors have included in the last paragraph that the "initial infarct size" is of importance for assessment of therapeutic interventions. If they imply that a measure of such variable is the initial endocardial length of abnormal contraction (dyskinesis/akinesis) segment (AS), serial routine echocardiography may suffice; if they mean that "initial infarct size" is only provided by the initial contrast defect segment (CD) (which requires the intracoronary injection of contrast medium), this contradicts their findings (AS/CD=1.00±0.02). Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction.trast echocardiography in acute myocardial ischemia, I: in vivo determination of total left ventricular "area at risk. between segmental abnormalities and global left ventricular function in coronary artery disease: validation of a theoretical …

First victim, later aggressor: How the intestinal microbiota drives the pro-inflammatory effects of dietary emulsifiers?

Direct impact of commonly used dietary emulsifiers on human gut microbiota

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

Dietary Emulsifiers Alter Composition and Activity of the Human Gut Microbiota in vitro, Irrespective of Chemical or Natural Emulsifier Origin

Maternal diet alters offspring early life host-microbiota communication through goblet cells, resulting in long-lasting diseases susceptibility

A novel COL7A1 mutation in a Korean patient with Hallopeau-Siemens recessive dystrophic epidermolysis bullosa.

Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases

Functional improvement in stunned myocardium.

In Inflammatory Bowel Disease and Extraintestinal Manifestations: What Role Does Microbiome Play?

Different recombinant murine leukemia viruses use different cell surface receptors.

The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice

Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation

Dietary Exposures to Common Emulsifiers and Their Impact on the Gut Microbiota: Is There a Cause for Concern?

Insights Into Inflammatory Bowel Disease and Effects of Dietary Fatty Acid Intake With a Focus on Polyunsaturated Fatty Acids Using Preclinical Models

The Role of Diet and Gut Microbiota in Regulating Gastrointestinal and Inflammatory Disease

Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease

Impact of Food Additives on Gut Homeostasis

Motor training in the therapy of Parkinson's disease